Advance the development of potent, cross-reactive multispecific antibodies for the prep countermeasure of covid-19 and seasonal and highly pathogenic avian influenza.
Active Definitive Contract Awarded Last action
- Contract number
- 75A50123C00056
- Awardee
-
Modex Therapeutics, Inc. UEI CDVMNSMRDTW8
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $103,516,903
Award facts
- Opportunity
-
- BAA18100SOL0003 Solicitation number
- Contract value 52% obligated
-
- $103,516,903.00 Current, with exercised options
- $198,470,844.00 Potential, with all options
- Completion date 49% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Natick, MA 01760, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$6,532,259 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $34,999,576 | |
| Exercise an Option | $16,049,691 | |
| Original award | $58,999,895 |
About this award
The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $198.5 million definitive contract to Modex Therapeutics, Inc. on September 27, 2023, to advance development of potent, cross-reactive multispecific antibodies for PrEP countermeasures against COVID-19 and seasonal and highly pathogenic avian influenza.
Work is performed in Natick, Massachusetts. The contract runs through January 18, 2030, on a cost-plus-fixed-fee basis with no set-aside. The award included updates to key personnel, adjustment of the change-of-scope threshold to $350,000 per current regulations, and alignment of FAR and HHSAR clauses with executive orders and current regulations.
In fiscal year 2024, the contractor invoiced $21.4 million across 7.1 FTEs and 14,804 contractor hours, yielding a government-paid rate of $1,445.13 per hour. The prime self-performed all reported work without subcontractor engagement in that fiscal year.
Quick answers
Who was awarded contract 75A50123C00056?
75A50123C00056 was awarded to Modex Therapeutics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 27, 2023.
How much is contract 75A50123C00056 worth?
The government has obligated $103,516,903 on 75A50123C00056. Its potential value, with all options, is $198,470,844.
Was contract 75A50123C00056 competed?
The extent of competition for 75A50123C00056 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award